glp 1 and addiction GLP-1 medications are getting attention for their potential in care. Here's what the research is finding. #AddictionTreatment #GLP1 #EmergingResearch GLP-1 drugs may fight addiction

Retrieved 24 October 2023

Su accin selectiva, sin elevar los niveles de cortisol o prolactina, lo convierte en un foco de investigacin que requiere una respuesta hormonal estable

Given that obesity is a chronic and relapsing disease, it is important to understand the effectiveness of different strategies to maintain WL: TRIUMPH-6 (NCT06859268) will assess changes in bodyweight at 116 weeks in individuals with obesity who have completed 80 weeks of retatrutide, comparing continued treatment at high or low doses of retatrutide versus switching to placebo for the last 36 weeks

Faisal Z, Mazhar A, Batool SA, Akram N, Hassan M, Khan MU, Afzaal M, Hassan UU, Shah YA, Desta DT